Comparative Outcome Measures of Patients Receiving Acute Renal ThErapy Study

Completed

Conditions studied: End Stage Kidney Disease, End Stage Renal Disease, Acute Kidney Injury

In brief

Retrospective, multicenter, comparative, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Renal Disease or Acute Kidney Injury.

Key facts

Study ID

NCT04912024

Run by

Outset Medical

People needed

458

Starts

2021-05-15

Expected to finish

2022-06-15

Last updated by the study team

2022-08-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant is 18 years of age.
• Participant weighs ≥ 34kg.
• Participant was hospitalized and had dialysis dependent End-Stage Renal Disease or Acute Kidney Injury and was prescribed acute intermittent renal replacement therapy.

You may not qualify if…

• Treatments isolated to ultrafiltration only.
• Any documented condition the Physician feels would prevent the participant from successful inclusion in the study.

Where it is running

• Adventist Health System — Orlando, Florida, United States
• Texas Health Harris Methodist Hospital Fort Worth — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.